Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T16:11:50.568Z.
Calculation as of: 2026-10-06T16:11:50.568Z.
Quote observation: 2026-10-06T16:10:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e7bb4fe4bb3aa983eb4620adc8aa5d0f555a5020ff21ce65ee2b72f9631e0f85
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Dyne Therapeutics, Inc.
Market Cap
$2.88B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.82B
Operating Cash Flow Yield
5.18%
TTM Avg
4.84%
3Y Avg
2.97%
5Y Avg
2.97%
Market Cap
$2.79B
Operating Cash Flow Yield
2.33%
TTM Avg
3.24%
3Y Avg
1.81%
5Y Avg
1.81%
Market Cap
$2.73B
Operating Cash Flow Yield
N/A
TTM Avg
1.08%
3Y Avg
1.08%
5Y Avg
1.08%
Market Cap
$2.71B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.70B
Operating Cash Flow Yield
7.80%
TTM Avg
13.68%
3Y Avg
9.67%
5Y Avg
8.30%
Market Cap
$2.68B
Operating Cash Flow Yield
6.27%
TTM Avg
6.21%
3Y Avg
4.04%
5Y Avg
3.58%
Market Cap
$2.68B
Operating Cash Flow Yield
3.10%
TTM Avg
4.02%
3Y Avg
3.45%
5Y Avg
3.00%
Market Cap
$3.06B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | $2.88B | N/A | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.82B | 5.18% | 4.84% | 2.97% | 2.97% |
| AtriCure, Inc. (ATRC)vs › | $2.79B | 2.33% | 3.24% | 1.81% | 1.81% |
| Precigen, Inc. (PGEN)vs › | $2.73B | N/A | 1.08% | 1.08% | 1.08% |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.71B | N/A | N/A | N/A | N/A |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.70B | 7.80% | 13.68% | 9.67% | 8.30% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.68B | 6.27% | 6.21% | 4.04% | 3.58% |
| Neogen Corporation (NEOG)vs › | $2.68B | 3.10% | 4.02% | 3.45% | 3.00% |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.06B | N/A | N/A | N/A | N/A |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.07B | N/A | 9.93% | 9.93% | 9.93% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
